Abstract
Background and objectivesRestenosis is a serious complication after percutaneous coronary intervention (PCI) for patients with coronary heart disease (CHD). This prospective clinical study was designed to investigate the effects of liposomal prostaglandin E1 (lipo-PGE1) on coronary stenosis and restenosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have